Peer-reviewed article
Developmental Dysgraphia in Child and Adolescent Psychiatric-Mental Health Nursing: An Integrative Review.
Colin Blenis R ·
Summary
Written by AI, not yet AICS's view · claude-haiku-4-5-20251001This integrative review examines developmental dysgraphia (a writing disorder) affecting 5-20% of school-age children, with rates reaching 59% among children with ADHD or autism. The condition is associated with task avoidance, low self-esteem, and psychiatric presentations including anxiety, depression, and school refusal. The review synthesizes evidence from 56 studies across eight databases and finds that dysgraphia remains poorly identified in psychiatric evaluations despite its significant psychosocial burden. The authors recommend integrating dysgraphia screening into psychiatric assessments and adapting writing-based activities in clinical settings.
Key points
- Developmental dysgraphia affects 5-20% of school-age children and 59% of children with ADHD or autism
- More than 37% of children with learning disabilities meet clinical thresholds for affective and ADHD problems
- Dysgraphia is rarely identified within psychiatric evaluation despite its clinical footprint
- Only three nursing publications addressed dysgraphia and none reported original research on the condition
- Screening opportunities exist in pediatric primary care, school health, and psychiatric evaluations of children referred for ADHD, anxiety, depression, or behavioral disturbance
Limitations
This is a literature review that synthesizes existing evidence rather than conducting original research, so it cannot provide new data on dysgraphia prevalence, outcomes, or intervention effectiveness. The review does not specify which countries' literature was included, limiting geographic applicability.
Abstract
Background Developmental dysgraphia affects 5% to 20% of school-age children and reaches 59% among children with ADHD or autism. The condition produces task avoidance, eroded self-esteem, and behavioral presentations that frequently result in psychiatric referral for anxiety, depression, school refusal, and behavioral disturbance. More than 37% of children with learning disabilities reach clinical thresholds for affective and ADHD problems. Despite this clinical footprint, dysgraphia remains nosologically contested and rarely identified within psychiatric evaluation. Objectives This integrative review synthesizes the multidisciplinary evidence on developmental dysgraphia and examines its implications for child and adolescent psychiatric-mental health nursing. Data sources Eight databases (PubMed/MEDLINE, CINAHL, PsycINFO, Scopus, ERIC, Cochrane, OTseeker, Web of Science) yielded 8290 records published between January 2000 and March 2026. After deduplication, 6308 records were screened, 1476 were assessed for eligibility, and 56 contributed to synthesis. Synthesis followed Whittemore and Knafl (2005) under PRISMA 2020 reporting conventions. Conclusions Findings document definitional disagreement, fragmented assessment, underpowered intervention evidence, and substantial psychosocial burden. Three nursing publications addressed dysgraphia, and none reported original research on the condition. Implications for practice Dysgraphia screening may be integrated into psychiatric evaluations of children referred for ADHD, anxiety, depression, school refusal, or behavioral disturbance. Handwriting may be monitored as a stimulant medication outcome. On inpatient units, writing-based therapeutic activities require adaptation when dysgraphia is suspected. Pediatric primary care and school health represent upstream identification opportunities.